Carlos Blanco

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Topics

Respiratory Syndrome Coronavirus

Cross Sectional

Top Venues

Molecular psychiatry

Annals of internal medicine

Translational psychiatry

Psychological medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Mark Olfson, Chandler McClellan, Samuel H Zuvekas, Melanie M Wall, Carlos Blanco
Trends in Psychological Distress and Outpatient Mental Health Care of Adults During the COVID-19 Era. Annals of internal medicine (2024)
Guillaume Airagnes, Marina Sánchez-Rico, Amélia Deguilhem, Carlos Blanco, Mark Olfson, Charles Ouazana-Vedrines, Cédric Lemogne, Frederic Limosin, Nicolas Hoertel
Nicotine dependence and incident psychiatric disorders: prospective evidence from US national study. Molecular psychiatry (2024)
Mark Olfson, Melanie M Wall, Carlos Blanco
Fatal Drug Overdose Risks of Health Care Workers in the United States. Annals of internal medicine 177 (2) (2024)
Mark Olfson, Melanie M Wall, Carlos Blanco
Fatal Drug Overdose Risks of Health Care Workers in the United States. Annals of internal medicine 177 (2) (2024)
Carlos Blanco, Benjamin Apelberg, Brian A King, Wilson M Compton
Opportunities for advancing science to inform tobacco regulation in an evolving tobacco landscape. Molecular psychiatry (2024)
Mark Olfson, Chandler McClellan, Samuel H Zuvekas, Melanie M Wall, Carlos Blanco
Trends in Psychological Distress and Outpatient Mental Health Care of Adults During the COVID-19 Era. Annals of internal medicine 177 (3) (2024)
Mark Olfson, Chandler McClellan, Samuel H Zuvekas, Melanie M Wall, Carlos Blanco
Trends in Psychological Distress and Outpatient Mental Health Care of Adults During the COVID-19 Era. Annals of internal medicine 177 (3) (2024)
Carlos Blanco, Leonie Kampe, Melanie M Wall, Shang-Min Liu, Shuai Wang, Eve Caligor, Mark Olfson
Approximating defense mechanisms in a national study of adults: prevalence and correlates with functioning. Translational psychiatry 13 (1) (2023)
Carlos Blanco, Leonie Kampe, Melanie M Wall, Shang-Min Liu, Shuai Wang, Eve Caligor, Mark Olfson
Approximating defense mechanisms in a national study of adults: prevalence and correlates with functioning. Translational psychiatry 13 (1) (2023)
Carlos Blanco, Leonie Kampe, Melanie M Wall, Shang-Min Liu, Shuai Wang, Eve Caligor, Mark Olfson
Approximating defense mechanisms in a national study of adults: prevalence and correlates with functioning. Translational psychiatry 13 (1) (2023)
Carlos Blanco, Melanie M Wall, Nicolas Hoertel, Robert F Krueger, Mark Olfson
Toward a generalized developmental model of psychopathological liabilities and psychiatric disorders. Psychological medicine (2022)
Carlos Blanco, Melanie M Wall, Mark Olfson
Data needs and models for the opioid epidemic. Molecular psychiatry (2021)
Carlos Blanco, Tisha R A Wiley, Jacqueline J Lloyd, Marsha F Lopez, Nora D Volkow
America's opioid crisis: the need for an integrated public health approach. Translational psychiatry 10 (1) (2020)
Carlos Blanco, Melanie M Wall, Mark Olfson
Psychological Aspects of the COVID-19 Pandemic. Journal of general internal medicine 35 (9) (2020)
Nora D Volkow, Carlos Blanco
The changing opioid crisis: development, challenges and opportunities. Molecular psychiatry 26 (1) (2020)
Pierre-Alexis Geoffroy, Maria A Oquendo, Philippe Courtet, Carlos Blanco, Mark Olfson, Hugo Peyre, Michel Lejoyeux, Frédéric Limosin, Nicolas Hoertel
Sleep complaints are associated with increased suicide risk independently of psychiatric disorders: results from a national 3-year prospective study. Molecular psychiatry 26 (6) (2020)
Melanie M Wall, Susan M Mason, Jun Liu, Mark Olfson, Dianne Neumark-Sztainer, Carlos Blanco
Childhood psychosocial challenges and risk for obesity in U.S. men and women. Translational psychiatry 9 (1) (2019)
Carlos Blanco, Melanie M Wall, Nicolas Hoertel, Robert F Krueger, Shang-Min Liu, Bridget F Grant, Mark Olfson
Psychiatric disorders and risk for multiple adverse outcomes: a national prospective study. Molecular psychiatry 26 (3) (2019)
Beth Han, Wilson M Compton, Carlos Blanco, Christopher M Jones
Time since first cannabis use and 12-month prevalence of cannabis use disorder among youth and emerging adults in the United States. Addiction (Abingdon, England) 114 (4) (2018)